| 发明名称 |
TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME |
| 摘要 |
A method of treating atypical hemolytic uremic syndrome. The method includes the step of administering orally or parenterally an effective amount of aurin tricarboxylic acid, aurin quadracarboxylic acid, and/or aurin hexacarboxylic acid, wherein the method excludes administration of components of aurin tricarboxylic acid complex of greater than or equal to 1 kilodalton in molecular weight. |
| 申请公布号 |
US2015065574(A1) |
申请公布日期 |
2015.03.05 |
| 申请号 |
US201414537674 |
申请日期 |
2014.11.10 |
| 申请人 |
Aurin Biotech Inc. |
发明人 |
McGeer Patrick L.;Lee Moonhee |
| 分类号 |
A61K31/194 |
主分类号 |
A61K31/194 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating atypical hemolytic uremic syndrome, the method comprising administering orally or parenterally an effective amount of aurin tricarboxylic acid, aurin quadracarboxylic acid, and/or aurin hexacarboxylic acid, wherein the method excludes administration of components of aurin tricarboxylic acid complex of greater than or equal to 1 kilodalton in molecular weight. |
| 地址 |
Vancouver CA |
